〔1〕杜伟,袁贵斌,汪永平,等. 介入法植入国产支架治疗前
列腺增生症的临床应用〔J〕. 大理学院学报,2010,9(2):
47-49.
〔2〕王守峰,张金岭,殷忠美,等. 不同Child 分级的高HB?
VDNA 滴度原发性肝癌介入治疗后肝功能损害的对比
研究〔J〕. 中国肿瘤外科杂志,2013,5(3):160-162.
〔3〕独建库,李冠海,张明德,等. 肝癌1063 例介入治疗并
发症处理的研究〔J〕. 临床军医杂志,2011,39(3):491-
493.
〔4〕SEN R,BALTIMORE D. Multiple nuclear factors interact
with the immunoglobulin enhancer Sequences〔J〕. Cell,
1986,46(5):705-716.
〔5〕AMEYA PARANJPE,KALKUNTE S,SRIVENUGOPAL.
Degradation of NF- κB,p53 and other regulatory redoxsensitive
proteins by thiolconjugating and nitrosylating
drugs in human tumor cells〔J〕. Carcinogenesis,2013,34
(5):990-1000.
〔6〕范伟,刘朝晖,张溪林,等. 慢性阻塞性肺疾病大鼠骨骼
肌中NF-кB 通路的研究〔J〕. 中国医学创新,2012,9
(18):15-17.
〔7〕AMIRI K I,RICHMOND A. Role of nuclear factor-kappa
B in melanoma〔J〕. Cancer Metastasis Rev,2005,24: 301-
313.
〔8〕KALALTZIDIS D,GILMORE T D. Transcription factor
cross- talk: the estrogen receptor and NF- kappa B〔J〕.
Trends Endocrinol Metab,2005,16:46-52.
〔9〕HUAN DENG,ZHENZHEN ZHOU,WEI TU,et al. AEG1
induces COX- 2 expression via activation of NF- κB and
AP- 1 in hepatoma HepG2 cells〔J〕. Chinese- German J
Clin Oncol,2013,12(6):253-256.
〔10〕KUO M T,LIU Z,WEI Y,et al. Induction of human
MDRl gene expression by 2-acelylaminofluoxene is medi?
ated by effectors of the phosphoinositide 3-kinase Path?
way that activate NF- kappa signaling〔J〕. Oncogene,
2002,21(13):1945-1954.
〔11〕齐京鹏,廖和和,王永峰,等. 不能手术的原发性肝癌
介入治疗与介入加放疗的疗效比较〔J〕. 现代肿瘤医
学,2011,19(3):528-530.
〔12〕陈爱云. 原发性肝癌介入手术治疗40 例围术期护
理〔J〕. 齐鲁护理杂志,2012,18(20):66-67.
〔13〕康建荣. 75 例肝癌介入术后并发症的观察及护理〔J〕.
中国实用医药,2012,7(7):216-217.
〔14〕杨玉琴. 膀胱癌术后化疗灌注的体会〔J〕. 大理学院学
报,2012,11(12):72-73.
〔15〕LAVON I,PIKARSKY E,GUTKOVICH E,et a1. Nucle?
ar fator-kappaB Protects the liver against genotoxic stress
and functions independently of p53〔J〕. Cancer Res,
2003,63(1): 25-30.
〔16〕AE-RI N,KATINKA P Z,PAUL P T,et al. Non-canoni?
cal NF-кB signaling in endothelial cells may enhance sy?
novial inflammation by stimulating angiogenesis〔J〕. Jour?
nal of Translational Medicine,2011,9(2):50.